Overall, 2018 showed favorable trends for opioid use with declines in both utilization and cost. Understanding the top opioid medications being filled and impacting spend can help guide decision-making and aid in identifying opportunities for intervention particularly through formulary controls, utilization management strategies, and through insight into regulatory changes and juris-specific rule application. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Ask The Pharmacist: The Hidden Risks of Gabapentin in Workers’ Compensation
What is gabapentin and why is it so commonly prescribed?Gabapentin was approved by the
Mitchell
Article
Plugged-In: EV Collision Insights 2025 Year in Review
Do
Mitchell
News Release
Electric Vehicle Collision Claims Rise 14% in the U.S. and 24% in Canada Even as Sales of New Models Slow
SAN DIEGO, Calif.—Mitchell, a leader in the development of innovative auto physical damage
PC360
Article
Legislative outlook for containing third-party litigation funding in 2026
Workers' Comp
Article
Prescription Drug Affordability: Why Work Comp Costs Keep Rising Despite Reform Efforts
Affordability seems to be the issue of the day, and the 2026 midterm elections will likely be decided on this perception.
Workers' Comp
Case Study